Monday, June 15, 2026

U.S. and South Korean Air Forces Conduct High-Stakes Live-Fire Exercises

The U.S. and South Korean Air Forces are conducting live-fire exercises from today until the 28th, using over 60 aircraft.

From National Fencing Icon to Suspended: Nam Hyun Hee’s 7-Year Ban Explained

Former national fencing team member Nam Hyun Hee has been officially sanctioned with a seven-year suspension.

North Korea’s Military Posture: Will New Short-Range Missiles Target South Korea?

North Korea's recent military parade lacked new weapons, raising speculation about upcoming provocations, particularly targeting South Korea.

Tag: drug

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Daewoong Pharmaceutical Gains Mexico Approval for Type 2 Diabetes Drug as Latin America Expansion Accelerates

Daewoong Pharmaceutical's type 2 diabetes drug Enblo has received approval in Mexico, a key market in Latin America.

Inventage Lab Showcases Next-Generation Monthly Obesity Injection Data Ahead of Global Experts at ADA

Inventage Lab presents its next-gen obesity treatment, reducing dosage frequency from weekly to monthly, to U.S. experts.

Inventage Lab Secures Patent for Semaglutide Formulation Aimed at Improving Oral Bioavailability

Inventage Lab secures a patent for a liposome formulation enhancing semaglutide's bioavailability, aiming to lead in obesity treatment.

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

KVMA and KIDS to Enhance the Safety Management of Narcotic Drugs in Veterinary Medicine

The KVMA and KIDS signed an MOU to enhance narcotic drug safety in veterinary medicine, promoting education and data utilization.

ADHD Medication Misconceptions: Why Korean Teens Are Misusing Study Drugs

ADHD medications are misused by teens as smart drugs. The Ministry of Food and Drug Safety expands education and AI monitoring to combat this.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

FDA Grants Orphan Drug Status to Tovecimig: What This Means for Cholangiocarcinoma Treatment

ABL Bio's Tovecimig receives Orphan Drug Designation from the FDA, enhancing its approval prospects for cholangiocarcinoma treatment.

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.